Gamco Investors INC. ET AL Increases Stock Holdings in DENTSPLY SIRONA Inc. $XRAY

Key Points

• Gamco Investors INC. ET AL increased its stake in DENTSPLY SIRONA by 21.5% in Q1, holding 116,793 shares valued at approximately $1.75 million.
• DENTSPLY SIRONA reported earnings per share (EPS) of $0.52 for the latest quarter, exceeding analyst expectations, despite a 4.9% decline in revenue compared to the previous year.
• The company declared a quarterly dividend of $0.16 per share, with a dividend yield of 4.5%, scheduled for payment on October 10th.

Gamco Investors INC. ET AL lifted its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 21.5% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 116,793 shares of the medical instruments supplier's stock after buying an additional 20,664 shares during the period. Gamco Investors INC. ET AL owned about 0.06% of DENTSPLY SIRONA worth $1,745,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the company. Vanguard Group Inc. increased its stake in DENTSPLY SIRONA by 2.8% in the 1st quarter. Vanguard Group Inc. now owns 20,740,589 shares of the medical instruments supplier's stock worth $309,864,000 after purchasing an additional 557,329 shares during the period. Price T Rowe Associates Inc. MD increased its stake in DENTSPLY SIRONA by 11.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 13,961,759 shares of the medical instruments supplier's stock worth $208,590,000 after purchasing an additional 1,412,517 shares during the period. Fuller & Thaler Asset Management Inc. increased its stake in DENTSPLY SIRONA by 4.7% in the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 12,077,949 shares of the medical instruments supplier's stock worth $180,445,000 after purchasing an additional 538,531 shares during the period. Lazard Asset Management LLC increased its stake in DENTSPLY SIRONA by 23.0% in the 4th quarter. Lazard Asset Management LLC now owns 8,044,228 shares of the medical instruments supplier's stock worth $152,678,000 after purchasing an additional 1,505,928 shares during the period. Finally, AQR Capital Management LLC increased its stake in DENTSPLY SIRONA by 245.1% in the 4th quarter. AQR Capital Management LLC now owns 2,893,023 shares of the medical instruments supplier's stock worth $54,389,000 after purchasing an additional 2,054,767 shares during the period. 95.70% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on XRAY shares. Wall Street Zen cut DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Barrington Research decreased their price target on DENTSPLY SIRONA from $21.00 to $18.00 and set an "outperform" rating on the stock in a research note on Friday, August 8th. Stifel Nicolaus decreased their price target on DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating on the stock in a research note on Friday, August 8th. Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a research report on Monday, July 21st. Finally, Wells Fargo & Company cut their price objective on DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating on the stock in a research report on Friday, August 8th. Two research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $18.64.

DENTSPLY SIRONA Price Performance

NASDAQ XRAY traded down $0.02 during trading on Friday, hitting $14.30. 1,864,538 shares of the stock traded hands, compared to its average volume of 3,832,729. The company has a market capitalization of $2.85 billion, a P/E ratio of -3.02, a price-to-earnings-growth ratio of 0.89 and a beta of 0.96. The firm has a 50-day simple moving average of $15.15 and a 200-day simple moving average of $15.32. The company has a quick ratio of 1.11, a current ratio of 1.69 and a debt-to-equity ratio of 1.13. DENTSPLY SIRONA Inc. has a 12-month low of $12.16 and a 12-month high of $27.48.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.02. The business had revenue of $936.00 million during the quarter, compared to analysts' expectations of $929.67 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The firm's revenue for the quarter was down 4.9% compared to the same quarter last year. During the same quarter last year, the business posted $0.49 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. As a group, analysts predict that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 4.5%. The ex-dividend date is Friday, September 26th. DENTSPLY SIRONA's dividend payout ratio (DPR) is currently -13.50%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.